Susan Hasty, Publisher
Table of Contents . . . February 15th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
AIDS-Related Non-Hodgkin Lymphoma - High-Dose Cytosine Arabinoside-Based Regimens Effective As Salvage Therapy
Infectious Disease Therapy - Quinolone Treatment Increases Risk Of False-Positive Drug Tests
AIDS And HIV Tuberculosis - Rifampicin Reduces Nevirapine Levels In Coinfected Patients
Acute Myelogenous Leukemia - Signal Transduction Inhibitor 571 Has Little Effect On Most Malignant Cells
Carcinogenesis - Molecular Clamp Shuts Down Cancer-Causing Protein
Dermatology - Clinical Trial Tests Gel For Treatment Of Precursor To Skin Cancer
Drug Development - Protein May Be Target For New Cancer Drugs
Hypercholesterolemia - Atorvastatin Improves Blood Rheology
Appointments - Carolyn Rynard Named VP Of Product Development
Appointments - Charles Deignan Promoted To Senior Director
Appointments - John Hotchkiss Joins AnVil Informatics
Appointments - New Chief Executive Officer Named
Appointments - Tracy Tsuetaki Joins Quintiles Transnational
Appointments - William Claypool Joins 3-Dimensional Pharmaceuticals Board
Attention Deficit Disorder - Shire Pharmaceuticals Will Combat Generic Competition With Adderall XR
Clinical Trials - Endo Pharmaceuticals Extends Warrant Tender Offer
Collaborations - Array BioPharma Announces Compound Acquisition Agreements With Pfizer
Drug Development - FDA Speeds Up Drug Approvals - Slightly
Drug Development - High Throughput RNAi Tool Developed For Drug Target Validation
Education And Training - Internship Program Announced By Academy Of Managed Care Pharmacy, Pfizer
Ethics - Consortium Aims To Improve Protection Of Human Research Subjects
Finance - Abbott Reports 20% Sales Increase In Fourth Quarter
Finance - Arena Pharmaceuticals Announces 4Q, Year-End Results
Finance - Forest Laboratories Reports Record Fiscal Third-Quarter Results
Hereditary Tyrosinemia Type I - FDA Approves Drug to Treat Rare Pediatric Liver Disease
Legal Issues - California Court Denies Class Certification To Rezulin Plaintiffs
Medical Materials - Pronova Biomedical AS Acquired By Norwegian Company
Ophthalmology - Akorn Receives FDA Approval To Launch Paremyd
Ophthalmology - Nutritional Supplement Eases Dry Eye Syndrome
Policy - Group Set To Improve Equality Of Access To New Medicines Across E.U.
Regulatory Issues - U.S. Congress Revamps Program To Study, Label Children's Drugs
Toxicology Screening - Biosite Receives Marketing Clearance For Drug Screen
Vitamin Deficiency - Nastech Receives Approval To Market Nascobal In Sweden
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.